Close

Usana Health Sciences, Inc. (USNA) Tops Q1 EPS by 21c; Boosts FY12 Revs Outlook

April 24, 2012 4:08 PM EDT
Usana Health Sciences, Inc. (NYSE: USNA) reported Q1 EPS of $0.90, $0.21 better than the analyst estimate of $0.69. Revenue for the quarter came in at $154.1 million versus the consensus estimate of $145.33 million.

Usana Health Sciences, Inc. sees FY2012 EPS of $3.60-$3.70, versus the consensus of $3.44. Usana Health Sciences, Inc. sees FY2012 revenue of $610-$625 million, versus prior guidance of $600-$615 million and the consensus of $611 million.

For earnings history and earnings-related data on Usana Health Sciences, Inc. (USNA) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings